MAPS enters its May 15 earnings event with short sellers meaningfully pulling back — and the borrow market confirming there is little conviction left on the bearish side.
Short interest has fallen sharply, dropping nearly 39% over the past month to 2.8% of the free float. That decline has accelerated in recent days: positions fell a further 5.4% in a single session on May 8. Borrow costs back that up — the cost to borrow has eased to 0.69%, and availability remains comfortably loose, with the lending pool far from tapped. The ORTEX short score has followed the same path, sliding from 38.6 on April 28 to 34.3 — a meaningful retreat from what was already a modest level.
Options positioning reinforces the lack of defensive urgency. The put/call ratio is running at just 0.054, barely above its 20-day average of 0.049. That is far below the 52-week high of 0.387, pointing to an options market where demand for downside protection is close to absent ahead of the print. The stock has gained 9.1% over the past week, recovering from a 3.1% monthly decline, and now trades at $0.38. The price is off its highs but has found near-term momentum.
The bull case rests on the company's value positioning. The ORTEX stock score's value component sits near the 79th percentile — the highest-ranked factor in the model — suggesting the market may be pricing in more weakness than the fundamentals support. Analyst estimates point to roughly $171 million in revenue and $29.6 million EBITDA for the full year, with net income of approximately $13.2 million. Operating cash flow is estimated near $24 million. Bears, meanwhile, will point to the momentum score — near the bottom of the universe at the 12th percentile — and to the stock's prolonged slide from above $1 just a year ago. Two recent prints produced negative price reactions: the stock fell 11% in a single day and 15.7% over five days after one event, and dropped 1.9% then 4% over the following week after another.
The CEO and General Counsel both sold shares in February, part of a pattern of consistent insider selling across at least three separate events over the past year. The net insider position over 90 days reflects $321,000 in sales at prices well above the current $0.38 — a detail the market will weigh against any forward guidance that implies stabilisation.
The May 15 print tests whether WM Technology's revenue trajectory and cash generation can persuade a sceptical market that the stock's prolonged de-rating has run its course.
See the live data behind this article on ORTEX.
Open MAPS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
